Related Experiment Video
Updated: Jun 16, 2026
08:39
High-throughput Image Analysis of Tumor Spheroids: A User-friendly Software Application to Measure the Size of Spheroids Automatically and Accurately
Published on: July 8, 2014
Multicellular tumor spheroids: an underestimated tool is catching up again
Franziska Hirschhaeuser1, Heike Menne, Claudia Dittfeld
1Institute of Physiology and Pathophysiology, University Medical Center of the Johannes Gutenberg-University Mainz, Duesbergweg 6, 55128 Mainz, Germany.
Journal of Biotechnology
|January 26, 2010
Summary
Tumor spheroids offer a 3D model that better mimics tumors than 2D cultures, improving anti-cancer drug testing and identifying promising therapies. These advanced models aid in developing next-generation cancer treatments.
Area of Science:
- Oncology
- Biotechnology
- Drug Discovery
Background:
- Classical 2D cell cultures (monolayers) lack the complexity of in vivo tumors.
- Tumor spheroids provide a 3D microenvironment that better replicates in vivo pathophysiological conditions.
- There is a need for improved preclinical models to enhance anti-cancer drug efficacy testing.
Purpose of the Study:
- To highlight the potential of tumor spheroids for anti-cancer therapy testing.
- To discuss standardization, automation, and analytical challenges in spheroid-based assays.
- To explore the application of microtechnologies for high-throughput spheroid screening.
Main Methods:
- Utilizing tumor spheroid mono- and cocultures as 3D models.
- Implementing microtechnologies like micropatterning and microfluidics for spheroid production.
- Developing and analyzing spheroid cultures, including tumor-immune cell cocultures.
- Investigating sphere-forming assays for cancer stem cell populations.
Main Results:
- Spheroids accurately model in vivo tumor characteristics, including gradients.
- Spheroid models can eliminate poor drug candidates early and identify drugs missed by 2D assays.
- Microtechnologies enable standardized spheroid mass production for high-throughput screening.
- Coculture models, especially with immune cells, are valuable for testing immunotherapies.
- Sphere-forming assays maintain and expand cancer stem cells, crucial for understanding tumor heterogeneity and cure.
Conclusions:
- Tumor spheroids represent a significant advancement over 2D models for anti-cancer drug development.
- Standardization and microtechnologies are key to realizing the full potential of spheroids in drug screening.
- Spheroid models, particularly those incorporating cancer stem cells and immune cells, are vital for next-generation cancer therapy development.
